104 related articles for article (PubMed ID: 1724327)
1. [Treatment with iloprost of critical ischemia of the lower limbs associated with cardiac insufficiency. Study of interaction with the pharmacokinetics of digoxin].
Cabane J; Penin I; Bouslama K; Benchouieb A; Giral P; Picard O; Wattiaux MJ; Cheymol G; Souvignet G; Imbert JC
Therapie; 1991; 46(3):235-40. PubMed ID: 1724327
[TBL] [Abstract][Full Text] [Related]
2. [Treatment with iloprost of critical ischemia of the lower limbs associated with cardiac insufficiency. Study of the interaction with pharmacokinetics of digoxin].
Cabane J; Bouslama K; Giral P; Benchouieb A; Picard O; Lebas J; Wattiaux MJ; Penin I; Souvignet G; Imbert JC
Rev Med Interne; 1991; 12(6):465-70. PubMed ID: 1724324
[TBL] [Abstract][Full Text] [Related]
3. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
Duthois S; Cailleux N; Lévesque H
J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
[TBL] [Abstract][Full Text] [Related]
4. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
[TBL] [Abstract][Full Text] [Related]
5. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
[TBL] [Abstract][Full Text] [Related]
6. [The role of iloprost in the treatment of critical ischemia of the limbs].
Poggesi L; Comeglio M
Ann Ital Med Int; 1993 Oct; 8 Suppl():71S-77S. PubMed ID: 7509614
[TBL] [Abstract][Full Text] [Related]
7. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency].
Cappelli R; Bicchi M; Arrigucci S; Boschi S; Guerrini M; Forconi S
Minerva Cardioangiol; 1999 Mar; 47(3):81-8. PubMed ID: 10389449
[TBL] [Abstract][Full Text] [Related]
8. Haemostatic effects of iloprost in patients with lower limb ischemia.
Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Soraci S; Bartolone S; Bagnato L; Barbera N
Panminerva Med; 1997 Sep; 39(3):202-4. PubMed ID: 9360422
[TBL] [Abstract][Full Text] [Related]
9. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
[TBL] [Abstract][Full Text] [Related]
10. Effect of Iloprost infusion on metabolism in critical limb ischemia, utilizing microdialysis. A pilot study.
Danielsson P; Metzsch C; Norgren L
Int Angiol; 2004 Sep; 23(3):259-62. PubMed ID: 15765041
[TBL] [Abstract][Full Text] [Related]
11. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
[TBL] [Abstract][Full Text] [Related]
12. [Randomized placebo-controlled studies of iloprost in treatment of lower limb critical ischaemia].
Kharazov AF
Angiol Sosud Khir; 2010; 16(3):27-33. PubMed ID: 21280291
[TBL] [Abstract][Full Text] [Related]
13. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
de Donato G; Gussoni G; de Donato G
Chir Ital; 2004; 56(6):769-80. PubMed ID: 15771029
[TBL] [Abstract][Full Text] [Related]
14. Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization.
Coppolino G; Buemi A; Bolignano D; Lacquaniti A; La Spada M; Stilo F; De Caridi G; Benedetto F; Loddo S; Buemi M; Spinelli F
J Surg Res; 2009 Nov; 157(1):e129-35. PubMed ID: 19589539
[TBL] [Abstract][Full Text] [Related]
15. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
[TBL] [Abstract][Full Text] [Related]
16. Short-term and long-term effects of one-week treatment with intravenous iloprost in critical limb ischemia patients (Leriche-Fontaine stage III and IV).
Meini S; De Franco V; Auteri A; Setacci C; Di Renzo M; Pieragalli D
Int Angiol; 2005 Mar; 24(1):64-9. PubMed ID: 15877001
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases.
Zulian F; Corona F; Gerloni V; Falcini F; Buoncompagni A; Scarazatti M; Martini G; Zacchello F
Rheumatology (Oxford); 2004 Feb; 43(2):229-33. PubMed ID: 12923288
[TBL] [Abstract][Full Text] [Related]
18. Iloprost: new indication. Not adequately assessed.
Prescrire Int; 1999 Apr; 8(40):49-50. PubMed ID: 10848061
[TBL] [Abstract][Full Text] [Related]
19. Plasma prothrombotic markers after a short- and middle term treatment with iloprost in arteriopathic patients with critical limb ischemia.
Ferlito S; Di Salvo MM; Attanasio L; Finocchiaro PM; Condorelli PM; Mazzone D
Panminerva Med; 1994 Jun; 36(2):76-9. PubMed ID: 7530356
[TBL] [Abstract][Full Text] [Related]
20. [Behavior of endothelin plasma levels during iloprost infusion in patients with severe ischemia in the lower extremities].
Battistelli S; Borgogni T; Gori S; Manasse G
Minerva Cardioangiol; 1995 Jun; 43(6):257-62. PubMed ID: 7566538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
